Back
Design Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
72
DSGN
Design Therapeutics, Inc.
Last Price:
$9.82
Seasonality Move:
-15.75%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiDesign Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 28.1% based on the past 4 years of stock performance.
-
Design Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Design Therapeutics, Inc. Stock Undervalued?The current Design Therapeutics, Inc. [DSGN] share price is $9.77. The Score for DSGN is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
DSGN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 28.1% based on the past 4 years of stock performance.
Design Therapeutics, Inc. Stock Rating
Buy
72
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. overpriced?
-
Design Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Design Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
10.31
52-Week Low:
2.60
Prediction Charts
Market Cap:
556.5M
Price in USD:
9.77
Volume:
296.6K
Beta:
1.65
Technical Analysis
SMA50:
7.21
SMA100:
6.18
SMA200:
5.10
52-Wk Change:
58.09%
Stock Predictions
-
Is Design Therapeutics, Inc. stock public?Yes, Design Therapeutics, Inc. is a publicly traded company.
-
What is the Design Therapeutics, Inc. stock quote today?The Design Therapeutics, Inc. stock price is 9.77 USD today.
-
How to buy Design Therapeutics, Inc. stock online?You can buy Design Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 7.47 | 7.43 | 7.73 | 7.24 |
| Nov-18 | 7.33 | 7.59 | 7.73 | 7.27 |
| Nov-19 | 7.50 | 7.34 | 7.77 | 7.25 |
| Nov-20 | 8.09 | 7.87 | 8.80 | 7.81 |
| Nov-21 | 7.86 | 8.35 | 8.46 | 7.82 |
| Nov-24 | 8.42 | 8.64 | 8.89 | 8.38 |
| Nov-25 | 8.76 | 9.41 | 9.45 | 8.21 |
| Nov-26 | 9.50 | 9.37 | 9.85 | 9.34 |
| Nov-28 | 9.40 | 9.39 | 9.59 | 9.07 |
| Dec-1 | 9.26 | 8.95 | 9.35 | 8.75 |
| Dec-2 | 9.00 | 8.94 | 9.21 | 8.58 |
| Dec-3 | 9.55 | 9.77 | 10.00 | 9.05 |
| Dec-4 | 9.68 | 9.82 | 10.02 | 9.33 |
| Dec-5 | 9.89 | 9.77 | 10.31 | 9.69 |
Design Therapeutics, Inc. Earnings
Design Therapeutics, Inc. Earnings Report: Per Share Design Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Design Therapeutics, Inc. Forecast Revenue Growth
Design Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Design Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.